Unknown

Dataset Information

0

Characterization of local and circulating bovine ?? T cell responses to respiratory BCG vaccination.


ABSTRACT: The Mycobacterium bovis Bacillus Calmette-Guerin (BCG) vaccine is administered parenterally to infants and young children to prevent tuberculosis (TB) infection. However, the protection induced by BCG is highly variable and the vaccine does not prevent pulmonary TB, the most common form of the illness. Until improved TB vaccines are available, it is crucial to use BCG in a manner which ensures optimal vaccine performance. Immunization directly to the respiratory mucosa has been shown to promote greater protection from TB in animal models. ?? T cells play a major role in host defense at mucosal sites and are known to respond robustly to mycobacterial infection. Their positioning in the respiratory mucosa ensures their engagement in the response to aerosolized TB vaccination. However, our understanding of the effect of respiratory BCG vaccination on ?? T cell responses in the lung is unknown. In this study, we used a calf model to investigate the immunogenicity of aerosol BCG vaccination, and the phenotypic profile of peripheral and mucosal ?? T cells responding to vaccination. We observed robust local and systemic M. bovis-specific IFN-? and IL-17 production by both ?? and CD4 T cells. Importantly, BCG vaccination induced effector and memory cell differentiation of ?? T cells in both the lower airways and peripheral blood, with accumulation of a large proportion of effector memory ?? T cells in both compartments. Our results demonstrate the potential of the neonatal calf model to evaluate TB vaccine candidates that are to be administered via the respiratory tract, and suggest that aerosol immunization is a promising strategy for engaging ?? T cells in vaccine-induced immunity against TB.

SUBMITTER: Guerra-Maupome M 

PROVIDER: S-EPMC6831659 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization of local and circulating bovine γδ T cell responses to respiratory BCG vaccination.

Guerra-Maupome Mariana M   McGill Jodi L JL  

Scientific reports 20191105 1


The Mycobacterium bovis Bacillus Calmette-Guerin (BCG) vaccine is administered parenterally to infants and young children to prevent tuberculosis (TB) infection. However, the protection induced by BCG is highly variable and the vaccine does not prevent pulmonary TB, the most common form of the illness. Until improved TB vaccines are available, it is crucial to use BCG in a manner which ensures optimal vaccine performance. Immunization directly to the respiratory mucosa has been shown to promote  ...[more]

Similar Datasets

| S-EPMC10089282 | biostudies-literature
| S-EPMC11295143 | biostudies-literature
| S-EPMC1941486 | biostudies-literature
| S-EPMC3490408 | biostudies-literature
| S-EPMC3583271 | biostudies-literature
| S-EPMC4318913 | biostudies-literature
| S-EPMC8336950 | biostudies-literature
| S-EPMC4065783 | biostudies-literature
| S-EPMC9355358 | biostudies-literature
| S-EPMC6392474 | biostudies-literature